<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 12: Pulmonary Vascular Disease and Acute Lung Injury</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="pulmonary-tuberculosis.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 85.7%;"></div>
                        </div>
                       <span class="progress-text">Lecture 12 of 14</span>
                    </div>
                    <a href="pulmonary-tumours.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">Lesson 12: Pulmonary Vascular Disease and Acute Lung Injury</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                <!-- START: learning-outcomes -->
                <section id="learning-outcomes" class="content-section" aria-labelledby="section-heading-1">
                    <h2 id="section-heading-1" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">Learning Outcomes</span>
                    </h2>
                    <div class="content-card">
                        <p>At the end of the lesson, the learner should be able to -</p>
                        <ol>
                            <li>Discuss the causes of pulmonary vascular disease</li>
                            <li>Discuss the pathology of pulmonary oedema</li>
                            <li>Discuss the pathology of pulmonary hypertension</li>
                            <li>Discuss the pathology of pulmonary embolism and infarction</li>
                            <li>Discuss the pathology of pulmonary respiratory distress syndrome</li>
                        </ol>
                    </div>
                </section>
                <!-- END: learning-outcomes -->

                <!-- START: intro-vascular -->
                <section id="intro-vascular" class="content-section" aria-labelledby="section-heading-2">
                    <h2 id="section-heading-2" class="section-heading">
                        <span class="heading-icon"></span>
                        <span class="heading-text">1.0 INTRODUCTION</span>
                    </h2>
                    <div class="content-card">
                        <p>Diseases of the cardiovascular (heart) system affect the lungs and diseases of the lungs affect the heart due to the unique anatomical and functional characteristics of the pulmonary vasculature in which the pressure in the pulmonary arteries is much lower than that in the systemic arteries and that the pulmonary artery is thinner than the systemic arterial system.</p>
                        <p>The term acute lung injury refers to a number of pulmonary lesions affecting mainly the endothelium and epithelium caused by various factors and affecting the vascular components, which in turn affect the lungs causing injury.</p>
                        <p>Vascular and haemodynamic diseases of the lung include -</p>
                        <ol>
                            <li>Pulmonary oedema and congestion</li>
                            <li>Pulmonary hypertension</li>
                            <li>Pulmonary embolism and infarction</li>
                            <li>Adult respiratory distress syndrome</li>
                            <li>Pulmonary vasculitis</li>
                            <li>Acute interstitial pneumonia</li>
                        </ol>
                    </div>
                </section>
                <!-- END: intro-vascular -->

                <!-- START: pulmonary-oedema -->
                <section id="pulmonary-oedema" class="content-section" aria-labelledby="section-heading-3">
                    <h2 id="section-heading-3" class="section-heading">
                        <span class="heading-icon"></span>
                        <span class="heading-text">PULMONARY OEDEMA</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">1.0 INTRODUCTION</h3>
                        <p>Pulmonary oedema is accumulation of fluid in the lung tissues (pulmonary interstitium) due to an increase fluid in the alveolar wall and if severe affects the alveolar spaces. The main cause is left ventricular failure, which results in increased pressure in the alveolar capillaries.</p>
                        <p>Fluid leaks into the pulmonary interstitium causing increased flow of fluid into the pulmonary lymphatics resulting in stiffness of the lungs giving rise to a subjective sensation of dyspnoea. Rupture of the capillaries in the pulmonary system allows leakage of red cells into the interstitium and alveoli. The haemoglobin is phagocytosed by the macrophages, which accumulate the iron pigment and lie in the alveoli and interstitium as the "heart failure cells".</p>
                        
                        <h3 class="subsection-heading">2.0 CAUSES</h3>
                        <ol>
                            <li>Haemodynamic disturbances (haemodynamic/cardiogenic oedema)
                                <ul>
                                    <li>a. Increased hydrostatic pressure (increased pulmonary venous pressure)
                                        <ul>
                                            <li>- Left heart (ventricular) failure - commonest</li>
                                            <li>- Volume overload</li>
                                            <li>- Pulmonary vein obstruction</li>
                                        </ul>
                                    </li>
                                    <li>b. Reduced oncotic pressure - less common
                                        <ul>
                                            <li>- Hypoalbuminaemia</li>
                                            <li>- Nephrotic syndrome</li>
                                            <li>- Liver disease</li>
                                            <li>- Protein losing enteropathy</li>
                                        </ul>
                                    </li>
                                    <li>c. Lymphatic obstruction - rare</li>
                                </ul>
                            </li>
                            <li>Oedema due to micro vascular injury (alveolar injury)
                                <ul>
                                    <li>a. Infections
                                        <ul>
                                            <li>- Pneumonia</li>
                                            <li>- Septicaemia</li>
                                        </ul>
                                    </li>
                                    <li>b. Inhaled gases
                                        <ul>
                                            <li>- Oxygen</li>
                                            <li>- Smoke</li>
                                        </ul>
                                    </li>
                                    <li>c. Liquid aspiration
                                        <ul>
                                            <li>- Gastric contents</li>
                                            <li>- Near drowning</li>
                                        </ul>
                                    </li>
                                    <li>d. Shock</li>
                                    <li>e. Trauma</li>
                                    <li>f. Radiation</li>
                                    <li>g. Transfusion related</li>
                                </ul>
                            </li>
                            <li>Oedema due to undetermined origin
                                <ul>
                                    <li>a. High altitude</li>
                                    <li>b. Neutrogena (CNS trauma)</li>
                                </ul>
                            </li>
                        </ol>

                        <h3 class="subsection-heading">3.0 PATHOGENESIS AND PATHOPHYSIOLOGY</h3>
                        <ol>
                            <li><strong>Haemodynamic</strong><p>Increased hydrostatic pressure due to left sided heart failure and congestive cardiac failure results in increased escape of fluid into the lung interstitium. The fluid accumulates initially in the basal regions where the hydrostatic pressure is greater in this region (dependent oedema)</p></li>
                            <li><strong>Microvascular Injury</strong><p>Injury to the capillaries of the alveolar septa result in increased permeability of the capillaries facilitating leakage of fluid and proteins into the interstitial spaces and alveolar (in severe situations)</p></li>
                        </ol>

                        <h3 class="subsection-heading">4.0 PATHOLOGY</h3>
                        <h4 class="subsubsection-heading">Macroscopy</h4>
                        <ul>
                            <li>Wet heavy lungs</li>
                            <li>Soggy lungs</li>
                        </ul>
                        <h4 class="subsubsection-heading">Microscopy</h4>
                        <ul>
                            <li>Engorged alveolar capillaries</li>
                            <li>Alveolar microhaemorrhages</li>
                            <li>Haemosiderin-laden macrophages (heart failure cells)</li>
                            <li>Fibrosis and thickening of alveolar walls</li>
                        </ul>

                        <h3 class="subsection-heading">5.0 CLINICAL FEATURES</h3>
                        <aside class="callout note" role="note"><p>- What are the clinical features?</p></aside>

                        <h3 class="subsection-heading">6.0 INVESTIGATIONS</h3>
                        <aside class="callout note" role="note">
                            <ul>
                                <li>- What investigations will be relevant?</li>
                                <li>- What parameters will be significant in these investigations?</li>
                            </ul>
                        </aside>

                        <h3 class="subsection-heading">7.0 COMPLICATIONS</h3>
                        <aside class="callout note" role="note"><p>- Outline the complications stating their pathophysiology and differentiating factors</p></aside>
                    </div>
                </section>
                <!-- END: pulmonary-oedema -->

                <!-- START: pulmonary-hypertension -->
                <section id="pulmonary-hypertension" class="content-section" aria-labelledby="section-heading-4">
                    <h2 id="section-heading-4" class="section-heading">
                        <span class="heading-icon"></span>
                        <span class="heading-text">PULMONARY HYPERTENSION</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">1.0 INTRODUCTION</h3>
                        <p>Pulmonary hypertension (increased pulmonary arterial pressure) is a systolic blood pressure in the pulmonary arterial circulation of >30 mmHg. The normal pressure in the pulmonary system is 30/15 mmHg and 3-8 mmHg in the arteries and veins respectively.</p>
                        <p>The most important causes of pulmonary hypertension are COAD (chronic obstructive airway disease), fibrosis of the lungs and chronic pulmonary venous congestion. Pulmonary hypertension causes structural damage to the pulmonary vessels resulting in increased work on the right side of heart and right ventricular failure (Corpulmonale)</p>
                        
                        <h3 class="subsection-heading">2.0 CLASSIFICATION</h3>
                        <p>Can be classified as -</p>
                        <ol>
                            <li>Primary</li>
                            <li>Secondary</li>
                        </ol>

                        <h3 class="subsection-heading">3.0 PRIMARY (IDIOPATHIC)</h3>
                        <h4 class="subsubsection-heading">Introduction</h4>
                        <p>This is uncommon and the causes are unknown.</p>
                        <h4 class="subsubsection-heading">Causes</h4>
                        <p>Suggested causes include - neurohormonal vasoconstrictor mechanism, unrecognized thrombo-embolism or amniotic fluid emboli during pregnancy, collagen vascular disease, veno-oclusive disease and familial occurrence.</p>
                        <h4 class="subsubsection-heading">Pathogenesis</h4>
                        <ul><li>- Unknown</li></ul>

                        <h3 class="subsection-heading">4.0 SECONDARY</h3>
                        <p>This occurs secondary to a lesion recognized in the heart of lungs. It is more common.</p>
                        <ol>
                            <li>Passive pulmonary hypertension
                                <ul>
                                    <li>- Commonest</li>
                                    <li>- Produced by lesions that increase pressure in the pulmonary veins (pulmonary venous congestion)
                                        <ul>
                                            <li>o Mitral valve disease (mitral stenosis)</li>
                                            <li>o Chronic left ventricular failure - severe systemic hypertension, aortic stenosis and myocardial fibrosis</li>
                                        </ul>
                                    </li>
                                </ul>
                            </li>
                            <li>Increased pulmonary blood flow (hyperkinetic or reactive pulmonary hypertension)
                                <ul>
                                    <li>- Cardiac shunts - PDA, ASD and VSD</li>
                                </ul>
                            </li>
                            <li>Vaso-occlusive /Mechanical arterial obstruction
                                <ul>
                                    <li>a. Obstruction - block in pulmonary circulation
                                        <ul>
                                            <li>- Multiple emboli/thrombosis</li>
                                            <li>- SCD</li>
                                            <li>- Schistosomiasis</li>
                                            <li>- Foreign body emboli (e.g. in drug addicts)</li>
                                        </ul>
                                    </li>
                                    <li>b. Obliteration - reduced pulmonary vascular bed by chronic parenchymal lung disease (destruction of lung capillary bed)
                                        <ul>
                                            <li>- Chronic emphysema, Chronic bronchitis</li>
                                            <li>- Bronchiectasis, Pulmonary tuberculosis</li>
                                            <li>- Pneumoconiosis</li>
                                            <li>- Interstitial fibrosis</li>
                                        </ul>
                                    </li>
                                    <li>c. Vasoconstrictive - widespread sustained hypoxia results in vasoconstriction and alveolar hyperventilation and pulmonary hypertension
                                        <ul>
                                            <li>- High altitude</li>
                                            <li>- Pathologic Obesity (Pickwickian syndrome)</li>
                                            <li>- Severe hyphoscoliosis</li>
                                            <li>- Upper airway disease causing tonsilar hypertrophy</li>
                                        </ul>
                                    </li>
                                </ul>
                            </li>
                            <li>Idiopathic</li>
                        </ol>

                        <h3 class="subsection-heading">5.0 PATHOLOGY</h3>
                        <h4 class="subsubsection-heading">Heart</h4>
                        <ul>
                            <li>- Right ventricular hypertrophy</li>
                            <li>- Right atrial dilatation</li>
                        </ul>
                        <h4 class="subsubsection-heading">Arteries and small pulmonary arteries</h4>
                        <ul>
                            <li>- Medial hypertrophy</li>
                            <li>- Thickening and reduplication of elastin</li>
                        </ul>
                        <h4 class="subsubsection-heading">Medium sized arteries</h4>
                        <p>Medial hypertrophy<br>Intimal thickening<br>Thickening of elastic<br>Adventitial fibrosis</p>
                        <h4 class="subsubsection-heading">Large arteries</h4>
                        <ul>
                            <li>- Atheromatous deposits</li>
                        </ul>

                        <h3 class="subsection-heading">6.0 CLINICAL FEATURES, 7.0 INVESTIGATIONS, 8.0 COMPLICATIONS</h3>
                        <aside class="callout note" role="note">
                             <ul>
                                 <li>What are the clinical features?</li>
                                 <li>- What investigations will be relevant?</li>
                                 <li>- What parameters will be significant in these investigations?</li>
                                 <li>- Outline the complications stating their pathophysiology and differentiating factors</li>
                             </ul>
                        </aside>
                    </div>
                </section>
                <!-- END: pulmonary-hypertension -->

                <!-- START: ards -->
                <section id="ards" class="content-section" aria-labelledby="section-heading-5">
                    <h2 id="section-heading-5" class="section-heading">
                        <span class="heading-icon"></span>
                        <span class="heading-text">Adult Respiratory Distress Syndrome (Diffuse Alveolar Damage)</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">1.0 INTRODUCTION</h3>
                        <p>Adult respiratory distress syndrome is also called shock lung, acute alveolar injury, traumatic wet- lungs, post-traumatic insufficiency. ARDS is a syndrome caused by diffuse alveolar capillary damage characterized by rapid onset of severe life threatening respiratory insufficiency, cyanosis and severe arterial hypoxaemia resulting in multiple organ failure. It occurs as a complication of numerous diverse conditions due to injury to the lung and systemic disorders.</p>

                        <h3 class="subsection-heading">2.0 CAUSES</h3>
                        <ol>
                            <li>Infections
                                <ul>
                                    <li>a. Sepsis</li>
                                    <li>b. Diffuse pulmonary infections - viral pneumonia, military tuberculosis, mycoplasma</li>
                                    <li>c. Gastric aspiration</li>
                                </ul>
                            </li>
                            <li>Physical injury
                                <ul>
                                    <li>a. Mechanical trauma - head injury</li>
                                    <li>b. Pulmonary contusions</li>
                                    <li>c. Near drowning</li>
                                    <li>d. Fractures with fat embolism</li>
                                    <li>e. Burns</li>
                                    <li>f. Ionizing radiations</li>
                                </ul>
                            </li>
                            <li>Inhaled irritants - Oxygen toxicity, Smoke, Metal fumes, War gases, Irritant gases and chemicals</li>
                            <li>Chemical injuries - Heroin, ASA, Paraquat, Barbiturate overdose</li>
                            <li>Haematological- Multiple transfusions , D.I.C</li>
                            <li>Pancreatitis</li>
                            <li>Uraemia</li>
                            <li>Cardiopulmonary by-pass</li>
                            <li>Hypersensitivity reactions</li>
                            <li>Organic solvents</li>
                        </ol>

                        <h3 class="subsection-heading">3.0 PATHOGENESIS</h3>
                        <aside class="callout note" role="note">
                            <h4 class="callout-title">Diagram 8.1: Pathogenesis of ARDS</h4>
                            <p>Acute Alveolar Damage</p>
                        </aside>

                        <h3 class="subsection-heading">4.0 PATHOLOGY</h3>
                        <p>Injury results in increased vascular permeability (involving mainly type I alveolar) and necrosis that affects both capillary endothelium and alveolar epithelium resulting in intra-alveolar oedema, congestion, fibrin deposition and eventually HYALINE MEMBRANE.</p>
                        <h4 class="subsubsection-heading">Macroscopy</h4>
                        <ol>
                            <li>Stiff, congested and heavy lungs</li>
                        </ol>
                        <h4 class="subsubsection-heading">Microscopy</h4>
                        <ol>
                            <li>Interstitial and intra-alveolar oedema</li>
                            <li>Necrosis of alveolar epithelium</li>
                            <li>Congestion and intra-alveolar haemorrhage</li>
                            <li>Fibrosis</li>
                            <li>Changes as those seen in bronchopneumonia</li>
                        </ol>

                        <h3 class="subsection-heading">5.0 CLINICAL FEATURES</h3>
                        <ol>
                            <li>Profound dyspnoea</li>
                            <li>Tachypnoea</li>
                            <li>Cyanosis</li>
                            <li>Hypoxaemia</li>
                            <li>Respiratory distress</li>
                        </ol>

                        <h3 class="subsection-heading">6.0 INVESTIGATIONS</h3>
                        <ol>
                            <li>Chest X-ray - diffuse bilateral infiltrates</li>
                            <li>Lung volumes</li>
                            <li>Blood counts</li>
                        </ol>

                        <h3 class="subsection-heading">7.0 COMPLICATIONS</h3>
                        <aside class="callout note" role="note"><p>- Outline the complications stating their pathophysiology and differentiating factors</p></aside>
                    </div>
                </section>
                <!-- END: ards -->

                <!-- START: pulmonary-embolism -->
                <section id="pulmonary-embolism" class="content-section" aria-labelledby="section-heading-6">
                    <h2 id="section-heading-6" class="section-heading">
                        <span class="heading-icon"></span>
                        <span class="heading-text">PULMONARY EMBOLISM AND INFARCTION</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">1.0 INTRODUCTION</h3>
                        <p>Most emboli arise from deep leg veins (calf, popliteal, femoral and iliac veins) and passes in the venous circulation into the right heart and to the pulmonary arteries. Pulmonary embolism is a common preventable condition that can cause arterial occlusion resulting in infarction.</p>
                        <p>There are two main consequences of embolization to the pulmonary arterial tree increased pulmonary arterial pressure (affects right heart) and ischaemia of the lungs. If 60% of pulmonary vasculature is blocked suddenly (massive pulmonary embolism), the heart cannot pump blood (cardiovascular collapse) through the lungs causing sudden death. Blockage of middle-sized arteries results in major pulmonary embolism. 80% of the cases result in small emboli (minor pulmonary embolism)</p>
                        
                        <h3 class="subsection-heading">2.0 PREDISPOSING FACTORS</h3>
                        <ol>
                            <li>Immobility and bed rest</li>
                            <li>Post operative period</li>
                            <li>Pregnancy and post partum</li>
                            <li>Oral contraceptive therapies with high oestrogen preparations</li>
                            <li>Nephrotic syndrome</li>
                            <li>Severe burns</li>
                            <li>Trauma</li>
                            <li>Cardiac failure</li>
                        </ol>

                        <h3 class="subsection-heading">3.0 CAUSES</h3>
                        <aside class="callout note" role="note">
                            <ol>
                                <li>What are the causes?</li>
                                <li>What is the pathogenesis of pulmonary embolism?</li>
                            </ol>
                        </aside>

                        <h3 class="subsection-heading">4.0 TYPES OF EMBOLI</h3>
                        <ol>
                            <li>Thromboembolism</li>
                            <li>Air</li>
                            <li>Bone marrow</li>
                            <li>Fat</li>
                            <li>Amniotic fluid</li>
                            <li>Foreign body</li>
                        </ol>

                        <h3 class="subsection-heading">5.0 PATHOPHYSIOLOGY</h3>
                        <p>Pathophysiologic response and clinical significance depends on extent of obstruction, number of emboli, status of the cardiovascular system and release of vasoactive amines(histamine or cerotenin).</p>
                        
                        <h3 class="subsection-heading">6.0 CLINICAL FEATURES</h3>
                        <ol>
                            <li>Chest pain</li>
                            <li>Dyspnoea</li>
                            <li>Tachypnoea</li>
                            <li>Fever</li>
                            <li>Cough</li>
                            <li>Haemoptysis</li>
                            <li>Pleural rub</li>
                            <li>Severe - sudden death</li>
                        </ol>
                    </div>
                </section>
                <!-- END: pulmonary-embolism -->
            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="pulmonary-tuberculosis.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 85.7%;"></div>
                        </div>
                       <span class="progress-text">Lecture 12 of 14</span>
                    </div>
                    <a href="pulmonary-tumours.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>